//
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
Clinical epidemiology of heart failure with preserved ejection fraction (HFpEF) in comparatively young hospitalized patients
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial